Zusammenfassung
Hintergrund
Die Symptome einer akuten Kohlenmonoxid(CO-)Vergiftung sind unspezifisch und reichen von Kopfschmerzen bis zu Bewusstlosigkeit und Tod. Neben den Akutsymptomen können schwere neurologische Spätschäden auftreten. Die Zahl der in Deutschland amtlich registrierten Todesfälle aufgrund von CO-Vergiftung steigt an. Es liegen keine umfassenden Daten zur klinischen Symptomatik, zum Verlauf sowie zur Versorgungsqualität vor.
Methode
Als Grundlage dienen die Behandlungsdaten aller zwischen 2013 und 2017 im überregionalen Druckkammerzentrum (DKZ) Wiesbaden behandelten Patienten mit CO-Vergiftung. Ziele waren die vergleichende Darstellung von demografischen Daten, Vergiftungsquellen, initialen Symptomen, Behandlungsverläufen sowie die Auswertung von zeitlichen Abläufen der präklinischen und stationären Versorgung.
Ergebnis
Zwischen 2013 und 2017 wurden 476 Patienten mit einem durchschnittlichen CO-Hb-Anteil von 15 % (Q0,25 = 7,6 %; Q0,75 = 22,3 %) in der Blutgasanalyse (BGA) erfasst. Die häufigsten Symptome umfassten Kopfschmerzen, Schwindel, Übelkeit und Synkopen. Insgesamt vergingen vom medizinischen Erstkontakt bis zum BGA-Nachweis 91 min (Q0,25 = 53 min; Q0,75 = 147 min). Insgesamt verstarben 6 Patienten, 430 Patienten zeigten sich im Verlauf symptomfrei, 40 Patienten berichteten auch nach Abschluss der Behandlung über Symptome.
Schlussfolgerung
Die Analyse zeigt eine lange Zeitspanne zwischen Diagnosestellung und Behandlungsbeginn. Neben CO-Quellen wie Brand, Verbrennungsöfen und Holzkohlegrills zeigte sich eine hohe Anzahl von Intoxikationen nach Wasserpfeifenkonsum. Diese Studie unterstreicht die Notwendigkeit, bei Vorliegen unspezifischer neurologischer Symptome insbesondere bei jungen Patienten die Differenzialdiagnose CO-Vergiftung zu berücksichtigen und bei begründetem Verdacht unverzüglich zu behandeln.
Abstract
Background
The symptoms of acute carbon monoxide (CO) poisoning are unspecific, ranging from headaches to unconsciousness and death. In addition to acute symptoms, delayed severe neurological sequelae may occur. While a total of 440 deaths by CO poisoning were registered in Germany in 1999, a total of 594 patients died (0.73 per 100,000 inhabitants) in 2014 and in 2015 the number even increased to 648 deaths. A national database on clinical symptoms, course of illness or quality of care concerning CO poisoning does not yet exist.
Methods
The treatment data of patients admitted to the Hyperbaric Emergency Centre Wiesbaden (HEC) from 2013 to 2017 with CO poisoning formed the basis of the study. This was a comparative evaluation of patient demographics, poisoning sources, symptom spectrum, course of treatment and time intervals registered on the preclinical and clinical levels.
Results
From 2013 to 2017 a total of 476 patients (282 men and 194 women) with an average non-invasively measured CO-Hb of 15% (Q0.25 = 7.6%, Q0.75 = 22.3%) were treated with hyperbaric oxygen. Heaters (n = 131), charcoal barbecues (n = 93), fires (n = 90), hookahs (n = 78) and combustion engines (n = 37) were the most frequent CO sources identified. Headaches, vertigo, nausea and syncope were the most prevalent symptoms. A median of 91 min (Q0.25 = 53 min; Q0.75 = 147 min) passed between first medical contact and BGA-validated diagnosis. In total, 151 patients were transferred directly to the HEC, whereas 325 patients were secondarily transferred. The delay in this subgroup took 183 min (median Q0.25 = 138 min; Q0.75 = 248 min). After receiving the first hyperbaric treatment, 80% were free of symptoms. Remaining symptoms included headache (10%), fatigue (8%), vertigo (5%) and nausea (3%) and 45 patients terminated further treatment. Of the patients 417 received a second hyperbaric treatment and 370 patients were treated 3 times. After the third treatment, 89% were free of symptoms and 5% still reported headaches, 3% vertigo and 2% fatigue. In total, 6 patients died and 430 patients were symptom-free after treatment.
Conclusion
Commonly known sources (fire, charcoal grills) aside, many poisonings by smoking a hookah were observed. This study highlights the importance of considering CO poisoning as a differential diagnosis when encountering patients, especially of younger age, with non-specific neurological symptoms, as well as the importance of early initiation of treatment. A direct correlation between CO-Hb values (whether measured noninvasively or by invasive BGA) and the initial symptoms could not be demonstrated. In total, substantial time expired between the diagnosis and start of treatment of patients transported to a primary care hospital compared to those transported directly to the HEC. Although analysis showed adequate treatment with oxygen in the preclinical interval, administration of oxygen during primary hospital stay showed room for improvement. Introducing a national CO poisoning register and uniform treatment guidelines could improve in-house clinical processes. Multicenter studies are needed to close the gaps identified in the quality of care in Germany.
Literatur
Akyol S, Erdogan S, Idiz N et al (2014) The role of reactive oxygen species and oxidative stress in carbon monoxide toxicity: an in-depth analysis. Redox Rep 19:180–189. https://doi.org/10.1179/1351000214Y.0000000094
American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Carbon Monoxide Poisoning, Wolf SJ, Maloney GE et al (2017) Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute carbon monoxide poisoning. Ann Emerg Med 69:98–107.e6. https://doi.org/10.1016/j.annemergmed.2016.11.003
Brown SD, Piantadosi CA (1992) Recovery of energy metabolism in rat brain after carbon monoxide hypoxia. J Clin Invest 89:666–672. https://doi.org/10.1172/JCI115633
Buckley NA, Wolf SJ, Maloney GE et al (2011) Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute carbon monoxide poisoning. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD002041.pub3
Eichhorn L, Michaelis D, Kemmerer M et al (2017) Carbon monoxide poisoning from waterpipe smoking: a retrospective cohort study. Clin Toxicol (Phila). https://doi.org/10.1080/15563650.2017.1375115
Gesundheitsberichterstattung des Bundes. Suchstichwort: T58. Tabelle Sterbefälle, Sterbeziffern (ab 1998). Die Angaben für das Jahr 2016 wurden am 06.02.2019 ergänzt. http://www.gbe-bund.de/oowa921-install/servlet/oowa/aw92/dboowasys921.xwdevkit/xwd_init?gbe.isgbetol/xs_start_neu/&p_aid=3&p_aid=16629754&nummer=6&p_sprache=D&p_indsp=-&p_aid=27226617. Zugegriffen: 08.02.2019
Hampson NB (2016) U.S. mortality due to carbon monoxide poisoning, 1999–2014. Accidental and intentional deaths. Ann Am Thorac Soc 13:1768–1774. https://doi.org/10.1513/AnnalsATS.201604-318OC
Hampson NB, Dunn SL, UHMCS/CDC CO Poisoning Surveillance Group (2012) Symptoms of carbon monoxide poisoning do not correlate with the initial carboxyhemoglobin level. Undersea Hyperb Med 39:657–665
Hampson NB, Piantadosi CA, Thom SR, Weaver LK (2012) Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning. Am J Respir Crit Care Med 186:1095–1101. https://doi.org/10.1164/rccm.201207-1284CI
Hess DR (2017) Inhaled carbon monoxide: from toxin to therapy. Respir Care 62:1333–1342. https://doi.org/10.4187/respcare.05781
Huang C‑C, Ho C‑H, Chen Y‑C et al (2017) Hyperbaric oxygen therapy is associated with lower short- and long-term mortality in patients with carbon monoxide poisoning. Chest. https://doi.org/10.1016/j.chest.2017.03.049
Iqbal S, Law H‑Z, Clower JH et al (2012) Hospital burden of unintentional carbon monoxide poisoning in the United States, 2007. Am J Emerg Med 30:657–664. https://doi.org/10.1016/j.ajem.2011.03.003
Mathieu D, Marroni A, Kot J (2017) Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Diving Hyperb Med 47:24–32
Pace N, Strajman E, Walker EL (1950) Acceleration of carbon monoxide elimination in man by high pressure oxygen. Science 111:652–654
Piantadosi CA, Zhang J, Levin ED et al (1997) Apoptosis and delayed neuronal damage after carbon monoxide poisoning in the rat. Exp Neurol 147:103–114. https://doi.org/10.1006/exnr.1997.6584
Rose JJ, Wang L, Xu Q et al (2017) Carbon monoxide poisoning: pathogenesis, management, and future directions of therapy. Am J Respir Crit Care Med 195:596–606. https://doi.org/10.1164/rccm.201606-1275CI
Segersvärd H, Lakkisto P, Hänninen M et al (2017) Carbon monoxide releasing molecule improves structural and functional cardiac recovery after myocardial injury. Eur J Pharmacol 818:57–66. https://doi.org/10.1016/j.ejphar.2017.10.031
Statistisches Bundesamt Deutschland GENESIS-Online Ergebnisse der Todesursachenstatistik für Deutschland – Ausführliche vierstellige ICD10-Klassifikation – 2016 – Statistisches Bundesamt (Destatis). https://www.destatis.de/DE/Publikationen/Thematisch/Gesundheit/Todesursachen/Todesursachenstatistik.html. Zugegriffen: 08.02.2019
Thom SR, Bhopale VM, Fisher D et al (2004) Delayed neuropathology after carbon monoxide poisoning is immune-mediated. Proc Natl Acad Sci U S A 101:13660–13665. https://doi.org/10.1073/pnas.0405642101
Weaver LK (2009) Carbon monoxide poisoning. N Engl J Med 360:1217–1225. https://doi.org/10.1056/NEJMcp0808891
Weaver LK, Hopkins RO, Chan KJ et al (2002) Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 347:1057–1067. https://doi.org/10.1056/NEJMoa013121
Weaver LK, Howe S, Hopkins R, Chan KJ (2000) Carboxyhemoglobin half-life in carbon monoxide-poisoned patients treated with 100 % oxygen at atmospheric pressure. Chest 117:801–808. https://doi.org/10.1378/chest.117.3.801
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
L. Eichhorn, B. Jüttner und K. Tetzlaff sind Vorstandsmitglieder in der Deutschen Gesellschaft für Tauch- und Überdruckmedizin e. V. B. Jüttner ist Sprecher der Sektion Hyperbarmedizin der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin. D. Michaelis ist ärztlicher Leiter des Druckkammerzentrums Wiesbaden. M. Kemmerer ist Geschäftsführer des Druckkammerzentrums Wiesbaden. M. Kieback gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag eine retrospektive Beobachtungsstudie. Von allen beteiligten Patienten liegt eine Einverständniserklärung zur Nutzung der erhobenen Daten vor. Diese Studie wurde durch die Ethikkommission der Universität Bonn (Nr. 058/17) legitimiert.
Rights and permissions
About this article
Cite this article
Eichhorn, L., Kieback, M., Michaelis, D. et al. Behandlung von Kohlenmonoxidvergiftungen in Deutschland. Anaesthesist 68, 208–217 (2019). https://doi.org/10.1007/s00101-019-0544-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00101-019-0544-8